Sunday, December 4, 2016

BRIEF-Novimmune grants Genentech exclusive option to license NI-0101

* Grants Genentech an exclusive option to license NI-0101,

its anti-TLR4 monoclonal antibody for treatment of rheumatoid

arthritis

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)